136 related articles for article (PubMed ID: 17097759)
21. Role of emphysema and airway obstruction in prognosis of lung cancer.
Gullón JA; Suárez I; Medina A; Rubinos G; Fernández R; González I
Lung Cancer; 2011 Feb; 71(2):182-5. PubMed ID: 20554345
[TBL] [Abstract][Full Text] [Related]
22. The role of neuron-specific enolase (NSE) and thymidine kinase (TK) levels in prediction of efficacy ofEGFR-TKIs in patients with advanced-stage NSCLC [corrected].
Fiala O; Pesek M; Finek J; Benesova L; Minarik M; Bortlicek Z; Topolcan O
Anticancer Res; 2014 Sep; 34(9):5193-8. PubMed ID: 25202114
[TBL] [Abstract][Full Text] [Related]
23. Non-BAC component but not epidermal growth factor receptor gene mutation is associated with poor outcomes in small adenocarcinoma of the lung.
Kobayashi N; Toyooka S; Ichimura K; Soh J; Yamamoto H; Matsuo K; Otani H; Jida M; Kubo T; Tsukuda K; Kiura K; Sano Y; Date H
J Thorac Oncol; 2008 Jul; 3(7):704-10. PubMed ID: 18594314
[TBL] [Abstract][Full Text] [Related]
24. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
25. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors.
Lee SJ; Lee JI; Nam DH; Ahn YC; Han JH; Sun JM; Ahn JS; Park K; Ahn MJ
J Thorac Oncol; 2013 Feb; 8(2):185-91. PubMed ID: 23328548
[TBL] [Abstract][Full Text] [Related]
26. PTEN and phosphorylated AKT expression and prognosis in early- and late-stage non-small cell lung cancer.
Lim WT; Zhang WH; Miller CR; Watters JW; Gao F; Viswanathan A; Govindan R; McLeod HL
Oncol Rep; 2007 Apr; 17(4):853-7. PubMed ID: 17342327
[TBL] [Abstract][Full Text] [Related]
27. Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-Akt-positive or never smoker patients with advanced non-small-cell lung cancer: the ONCOBELL trial.
Cappuzzo F; Ligorio C; Jänne PA; Toschi L; Rossi E; Trisolini R; Paioli D; Holmes AJ; Magrini E; Finocchiaro G; Bartolini S; Cancellieri A; Ciardiello F; Patelli M; Crino L; Varella-Garcia M
J Clin Oncol; 2007 Jun; 25(16):2248-55. PubMed ID: 17538169
[TBL] [Abstract][Full Text] [Related]
28. Histology and smoking status predict survival of patients with advanced non-small-cell lung cancer. Results of West Japan Oncology Group (WJOG) Study 3906L.
Kogure Y; Ando M; Saka H; Chiba Y; Yamamoto N; Asami K; Hirashima T; Seto T; Nagase S; Otsuka K; Yanagihara K; Takeda K; Okamoto I; Aoki T; Takayama K; Yamasaki M; Kudoh S; Katakami N; Miyazaki M; Nakagawa K
J Thorac Oncol; 2013 Jun; 8(6):753-8. PubMed ID: 23575412
[TBL] [Abstract][Full Text] [Related]
29. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
30. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
[TBL] [Abstract][Full Text] [Related]
31. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
Pelletier MP; Edwardes MD; Michel RP; Halwani F; Morin JE
Can J Surg; 2001 Jun; 44(3):180-8. PubMed ID: 11407827
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival.
Dai J; Jin G; Dong J; Chen Y; Xu L; Hu Z; Shen H
J Thorac Oncol; 2010 Nov; 5(11):1748-54. PubMed ID: 20881643
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumor size.
Ou SH; Zell JA; Ziogas A; Anton-Culver H
Chest; 2008 Mar; 133(3):662-9. PubMed ID: 17925418
[TBL] [Abstract][Full Text] [Related]
34. The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.
Kim YT; Seong YW; Jung YJ; Jeon YK; Park IK; Kang CH; Kim JH
J Thorac Oncol; 2013 Feb; 8(2):171-8. PubMed ID: 23287850
[TBL] [Abstract][Full Text] [Related]
35. Clinical relevance of galectin-1 expression in non-small cell lung cancer patients.
Carlini MJ; Roitman P; Nuñez M; Pallotta MG; Boggio G; Smith D; Salatino M; Joffé ED; Rabinovich GA; Puricelli LI
Lung Cancer; 2014 Apr; 84(1):73-8. PubMed ID: 24560493
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: re-analysis of the SATURN study.
Mazières J; Brugger W; Cappuzzo F; Middel P; Frosch A; Bara I; Klingelschmitt G; Klughammer B
Lung Cancer; 2013 Nov; 82(2):231-7. PubMed ID: 23972450
[TBL] [Abstract][Full Text] [Related]
37. Node-negative non-small cell lung cancer: pathological staging and survival in 1765 consecutive cases.
Robinson BM; Kennedy C; McLean J; McCaughan BC
J Thorac Oncol; 2011 Oct; 6(10):1691-6. PubMed ID: 21869717
[TBL] [Abstract][Full Text] [Related]
38. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma.
Ebright MI; Zakowski MF; Martin J; Venkatraman ES; Miller VA; Bains MS; Downey RJ; Korst RJ; Kris MG; Rusch VW
Ann Thorac Surg; 2002 Nov; 74(5):1640-6; discussion 1646-7. PubMed ID: 12440623
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.
He YY; Zhang XC; Yang JJ; Niu FY; Zeng Z; Yan HH; Xu CR; Guan JL; Zhong WZ; Yang LL; Guo LH; Wu YL
Clin Lung Cancer; 2014 Nov; 15(6):441-7. PubMed ID: 25044104
[TBL] [Abstract][Full Text] [Related]
40. Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations.
Yeo CD; Park KH; Park CK; Lee SH; Kim SJ; Yoon HK; Lee YS; Lee EJ; Lee KY; Kim TJ
Lung Cancer; 2015 Mar; 87(3):311-7. PubMed ID: 25617986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
